D05.81 Other specified type of carcinoma in situ of right breast

Name of the Condition

• Other specified type of carcinoma in situ of right breast

Summary

Other specified type of carcinoma in situ of the right breast refers to non-invasive abnormal cell growth that remains localized within the breast tissue. It is an early-stage breast condition where cancerous cells have not spread beyond their original site. This category includes specific subtypes of in situ carcinoma that are not classified under more common types like ductal or lobular carcinoma in situ.

Causes

The exact cause is not fully understood, but it involves genetic mutations that disrupt normal cell growth regulation. Hormonal influences and other cellular changes may contribute to the development of these localized abnormalities.

Risk Factors

• Advancing age, particularly in post-menopausal individuals.
• Family history of breast cancer.
• Genetic predispositions, such as mutations in BRCA1 or BRCA2 genes.
• Prior breast conditions, including atypical hyperplasia or previous in situ carcinomas.
• Prolonged estrogen exposure.

Symptoms

• Often asymptomatic and detected during routine screening.
• May present as a small, localized lump or changes in breast texture in rare cases.
• Nipple discharge is uncommon but possible.

Diagnosis

Diagnosis typically begins with mammography, which may reveal microcalcifications or tissue abnormalities. Further evaluation often includes a biopsy to examine tissue samples under a microscope for confirmation. Additional imaging, such as MRI, may be used in specific cases to assess the extent of the lesion.

Treatment Options

Treatment depends on the subtype, size, and location of the lesion. Options may include surgical excision (lumpectomy or mastectomy), radiation therapy to eliminate remaining abnormal cells, and hormonal therapy if the cancer is hormone receptor-positive. The choice of treatment is individualized based on clinical factors.

Prognosis and Follow-Up

Prognosis is generally favorable due to the localized nature of the condition. Regular follow-up, including mammography and clinical exams, is recommended to monitor for recurrence or new abnormalities. Long-term surveillance helps detect any changes early.

Complications

Complications are rare but may include infection at the surgical site, lymphedema (if lymph nodes are involved), or recurrence of the in situ carcinoma. Radiation therapy may cause temporary skin irritation or fatigue.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including regular exercise, a balanced diet, and limiting alcohol intake, may support overall breast health. Routine breast self-exams and adherence to recommended screening guidelines (e.g., mammography) are important for early detection.

When to Seek Professional Help

Seek medical attention if you notice a new lump, changes in breast texture, nipple discharge, or skin changes (e.g., dimpling or redness). Prompt evaluation is recommended for any concerning breast symptoms, even if asymptomatic screening is up to date.

Tips for Medical Coders

Document the specific subtype of in situ carcinoma and the laterality (right breast) clearly in the medical record. Ensure the diagnosis aligns with the clinical findings and imaging results. Code D05.81 is appropriate when the carcinoma in situ is of a specified type other than ductal or lobular and is localized to the right breast.